| Evolution of insulin delivery devices: from syringes, pens, and pumps to DIY artificial pancreas J Kesavadev, B Saboo, MB Krishna, G Krishnan Diabetes Therapy 11 (6), 1251-1269, 2020 | 165 | 2020 |
| Once‐daily initiation of basal insulin as add‐on to metformin: a 26‐week, randomized, treat‐to‐target trial comparing insulin detemir with insulin glargine in patients with … L Meneghini, J Kesavadev, M Demissie, A Nazeri, P Hollander Diabetes, obesity and metabolism 15 (8), 729-736, 2013 | 89 | 2013 |
| Cost-effective use of telemedicine and self-monitoring of blood glucose via Diabetes Tele Management System (DTMS) to achieve target glycosylated hemoglobin values without … J Kesavadev, A Shankar, PBS Pillai, G Krishnan, S Jothydev Diabetes technology & therapeutics 14 (9), 772-776, 2012 | 78 | 2012 |
| The do-it-yourself artificial pancreas: a comprehensive review J Kesavadev, S Srinivasan, B Saboo, M Krishna B, G Krishnan Diabetes Therapy 11, 1217-1235, 2020 | 76 | 2020 |
| Barriers and solutions to diabetes management: An Indian perspective SK Wangnoo, D Maji, AK Das, PV Rao, A Moses, B Sethi, ... Indian Journal of Endocrinology and Metabolism 17 (4), 594-601, 2013 | 74 | 2013 |
| Diabetes in old age: an emerging epidemic JD Kesavadev, KR Short, KS Nair Journal-Association Of physicians of India 51, 1083-1094, 2003 | 71 | 2003 |
| Unproven therapies for diabetes and their implications J Kesavadev, B Saboo, S Sadikot, AK Das, S Joshi, R Chawla, H Thacker, ... Advances in therapy 34, 60-77, 2017 | 62 | 2017 |
| Forum for injection technique and therapy expert recommendations, India: the Indian recommendations for best practice in insulin injection technique, 2017 N Tandon, S Kalra, YPS Balhara, MP Baruah, M Chadha, HB Chandalia, ... Indian Journal of Endocrinology and Metabolism 21 (4), 600-617, 2017 | 54 | 2017 |
| Reduction of glycosylated hemoglobin following 6 months of continuous subcutaneous insulin infusion in an Indian population with type 2 diabetes J Kesavadev, S Balakrishnan, S Ahammed, S Jothydev Diabetes technology & therapeutics 11 (8), 517-521, 2009 | 53 | 2009 |
| The SAGE study: global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM E Renard, H Ikegami, AG Daher Vianna, P Pozzilli, S Brette, Z Bosnyak, ... Diabetes/Metabolism Research and Reviews 37 (7), e3430, 2021 | 52 | 2021 |
| Suggested use of vaccines in diabetes J Kesavadev, A Misra, AK Das, B Saboo, D Basu, N Thomas, SR Joshi, ... Indian journal of endocrinology and metabolism 16 (6), 886-893, 2012 | 50 | 2012 |
| Use of insulin pumps in India: suggested guidelines based on experience and cultural differences J Kesavadev, AK Das, R Unnikrishnan, SR Joshi, A Ramachandran, ... Diabetes Technology & Therapeutics 12 (10), 823-831, 2010 | 47 | 2010 |
| Blood glucose levels should be considered as a new vital sign indicative of prognosis during hospitalization J Kesavadev, A Misra, B Saboo, SR Aravind, A Hussain, L Czupryniak, ... Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (1), 221-227, 2021 | 46 | 2021 |
| Telemedicine for diabetes care: An Indian perspective-feasibility and efficacy J Kesavadev, B Saboo, A Shankar, G Krishnan, S Jothydev Indian journal of endocrinology and metabolism 19 (6), 764-769, 2015 | 44 | 2015 |
| Challenges in Type 1 diabetes management in South East Asia: Descriptive situational assessment J Kesavadev, SM Sadikot, B Saboo, D Shrestha, F Jawad, K Azad, ... Indian journal of endocrinology and metabolism 18 (5), 600-607, 2014 | 44 | 2014 |
| A multicenter real-life study on the effect of flash glucose monitoring on glycemic control in patients with type 1 and type 2 diabetes RM Anjana, J Kesavadev, D Neeta, M Tiwaskar, R Pradeepa, S Jebarani, ... Diabetes technology & therapeutics 19 (9), 533-540, 2017 | 42 | 2017 |
| Steroid use during COVID-19 infection and hyperglycemia–What a physician should know A Sosale, B Sosale, J Kesavadev, M Chawla, S Reddy, B Saboo, A Misra Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (4), 102167, 2021 | 41 | 2021 |
| Assessing the therapeutic utility of professional continuous glucose monitoring in type 2 diabetes across various therapies: a retrospective evaluation J Kesavadev, R Vigersky, J Shin, PBS Pillai, A Shankar, G Sanal, ... Advances in therapy 34, 1918-1927, 2017 | 36 | 2017 |
| Use of retrospective continuous glucose monitoring for optimizing management of type 2 diabetes in India V Mohan, J Sunil, J Kesavadev, M Chawla, A Mutha, V Vijay, B Saboo, ... Journal of the Association of Physicians of India, 16-21, 2016 | 36 | 2016 |
| Sodium-glucose cotransporter-2 inhibitors in combination with other glucose-lowering agents for the treatment of type 2 diabetes mellitus S Kalra, J Kesavadev, M Chadha, GV Kumar Indian Journal of Endocrinology and Metabolism 22 (6), 827-836, 2018 | 30 | 2018 |
Unnikrishnan AGCEO and Endocrinologist, Chellaram Diabetes Institute, PuneVerified email at cdi.org.in
